George D. Yancopoulos

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Tarrytown, NY
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
By: Richard Gluckselig as attorney-in-fact For: George D. Yancopoulos
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for George D. Yancopoulos

Form 4 holding Bd. Co-Chair, President & CSO, Director

REGENERON PHARMACEUTICALS, INC.

Security class
Non-Qualified Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
09 Dec 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by George D. Yancopoulos

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .